Cladribine added to daunorubicin-cytarabine induction prolongs survival of FLT3-ITD+ normal karyotype AML patients (Q48104360)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cladribine added to daunorubicin-cytarabine induction prolongs survival of FLT3-ITD+ normal karyotype AML patients |
scientific article |
Statements
1 reference
Cladribine added to daunorubicin-cytarabine induction prolongs survival of FLT3-ITD+ normal karyotype AML patients (English)
1 reference
Wieslaw Wiktor Jedrzejczak
Aleksander Skotnicki
Agnieszka Wierzbowska
Jerzy Holowiecki
Sebastian Giebel
Olga Haus
Kazimierz Kuliczkowski
Katarzyna Borg
Malgorzata Calbecka
Slawomira Kyrcz-Krzemien
Malgorzata Jakobczyk
Justyna Gajkowska-Kulik
Marek Kielbinski
Anna Ejduk
Beata Piatkowska-Jakubas
Monika Paluszewska
Jolanta Libura
Dariusz Kata
Sylwia Czekalska
Karolina Karabin
Marta Pawelczyk
Magdalena Zawada
13 November 2015
1 reference